Product Information
PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.3974 per EA under NDC 72241003122. Its NADAC has been published 163 times since Aug 23, 2023.
FDA first approved this application on Aug 27, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241003122
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA212645FDA Approved
8/27/2021
TE Code
AB
On Market Since
10/20/2021
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 163 times since Aug 23, 2023, and over the history we have for it it has declined 42.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3974 per EA |
|---|---|
| All-time high | $0.9265 (Oct 11, 2023) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.3974 |
| Median price | $0.4974 |
| Average price | $0.5199 |
| Largest weekly change | -37.4% (Oct 18, 2023) |
| Weeks tracked | 163 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Modavar Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Paroxetine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Modavar Pharmaceuticals LLC, is $0.3974 per EA (NDC 72241003122), effective Sep 30, 2026.
How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 42.7%. It has been tracked across 163 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?
Since Aug 23, 2023, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $0.9265 (Oct 11, 2023), with a median of $0.4974 per EA.
Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PAROXETINE ER 37.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PAROXETINE ER 37.5 MG TABLET?
PAROXETINE ER 37.5 MG TABLET (NDC 72241003122) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.